BRK-B vs MGLD

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.

The Marygold Companies exhibits severe financial weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating a significant deterioration in fundamental health. While the company maintains a strong liquidity position with a current ratio of 3.90 and very low debt, it is plagued by negative profit margins (-11.85%) and shrinking year-over-year revenue growth (-4.50%). The combination of negative ROE, a bearish technical trend, and a high Price-to-Book ratio (2.08) for a loss-making entity suggests the stock is fundamentally overvalued. Despite a slight recovery in 1-year price performance, the long-term 5-year trend remains deeply negative (-67.5%).